So what was Monday? A bottom for stocks, just one of those oversold bouncy things, or something else?

So what was Monday? A bottom for stocks, just one of those oversold bouncy things, or something else?

Yesterday stocks reversed direction big time. After days of pounding lower the Standard & Poor’s 500 gained 1.89% and the Dow Jones Industrial Average added 1.17% The NASDAQ Composite climbed 3.41% and the NASDAQ 100 tacked on 3.29%. Even the small cap Russell 2000 gained 3.05%. On those numbers I ‘d say the days action looks like a big oversold bounce off of a truly terrible January. But dig a little deeper and it looks like something else–or maybe additional somethings–was going on.

Saturday Night Quarterback says, For the week ahead expect…

Saturday Night Quarterback says, For the week ahead expect…

Expect a week for positioning for the big news scheduled for next week and the week thereafter. The U.S. Food & Drug Administration’s vaccines advisory committee meets on December 8-10. Pfizer’s application for an emergency use authorization for its coronavirus vaccine is on the agenda. Since none of us has seen the data submitted to the FDA, we don’t know for sure, but Wall Street believes that the advisory committee will recommend approval of the vaccine. That could put the FDA on track to approving the vaccine within any where from a couple of days to a week or two. Various sources in the White House and at Pfizer have said that the vaccine could be on its way to American arms as soon as two days after approval. You can bet that a “Yes” from the advisory committee will move stocks–every bit of positive vaccine news has pushed stocks significantly higher over the last two weeks and there’s no reason to think that any positive FDA news would be any different. The Federal Reserve’s Open Market Committee meets on December 16